News Channels

15 May 2023 Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
15 May 2023 Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program
13 May 2023 GSK presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains
13 May 2023 Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113
13 May 2023 LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate
13 May 2023 Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause
12 May 2023 Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology
11 May 2023 Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586
11 May 2023 Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
11 May 2023 Extend Biosciences Announces Positive Data from Phase 1 Trial of EXT608 for the Treatment of Hypoparathyroidism
11 May 2023 CytoAgents Announces FDA Acceptance of IND Application for CTO1681 to Treat Cytokine Release Syndrome in Oncology
11 May 2023 Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint
10 May 2023 Codagenix Initiates Dosing in Phase 1 Study of Intranasal, Live-Attenuated RSV
10 May 2023 Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
10 May 2023 Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
10 May 2023 Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
10 May 2023 Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
10 May 2023 Amgen and TScan Therapeutics announce collaboration to identify novel targets in Crohn's disease
10 May 2023 HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B
10 May 2023 DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes into clinical trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up